阿普斯特在中国上市了吗?好购买吗？

Introduction: Apremilast is a new oral drug for the treatment of psoriasis and psoriatic arthritis. Its accessibility in the Chinese market is a concern for many patients. This article will comprehensively analyze the acquisition channels and relevant policy status of Apremilast in China from three aspects: drug listing status, purchase convenience and medical insurance coverage.

Is Apremilast available on the market in China

It has received marketing approval from the China National Medical Products Administration, but has not yet been included in the National Medical Insurance List.

Time to market

Apremilast was approved for marketing in China in 2021 under the trade name "Otelex". It was introduced by the original pharmaceutical company Amgen. It is the first oral PDE4 inhibitor approved for the treatment of psoriasis in China.

Scope of Indications

Indications approved in China include: treatment of adult patients with moderate to severe plaque psoriasis and adult patients with active psoriatic arthritis.

处方要求

阿普斯特属于处方药，患者需凭皮肤科或风湿免疫科医师开具的处方才能购买。

患者可通过国家药监局官网查询药品批准信息，或咨询医院专科医生获取最新用药指导。

Is Apremilast easy to buy?

As a marketed drug, Apremilast’s acquisition channels in China are relatively standardized, but the convenience of purchasing is still affected by many factors.

Hospital pharmacy supply

Most large hospital dermatology and rheumatology and immunology pharmacies have stocks in stock, but some grassroots hospitals may not have introduced them yet. Patients can call in advance to inquire about the drug reserves of the target hospital.

Sales in retail pharmacies

Large chain pharmacies can provide Apremilast, but patients need to present a valid prescription. Some pharmacies support appointment ordering services.

Online drug purchasing platform

Some regular pharmaceutical e-commerce platforms have launched Apremilast. The purchasing process includes online consultation, uploading prescriptions, pharmacist review and other links.

Patients are advised to choose formal channels to purchase and avoid obtaining drugs through unauthorized channels.

Is Apremilast included in the national medical insurance?

As of now, Apremilast has not been included in the national medical insurance drug list, and patients need to purchase it in full at their own expense.

Current status of medical insurance

Apremilast has not been included in the adjustment scope of the national medical insurance drug catalog, but some regions may include it in the supplementary catalog of critical illness insurance.

Price at your own expense

Apremilast produced by Glenmark Pharmaceuticals in India is available in two specifications. The price of 30mg*30 pills is about US$22 per box, and the price of 30mg*60 pills is about US$32 per box.

随着医保谈判机制的完善和更多临床数据的积累，阿普斯特有望在未来几年进入医保谈判程序。 Patients can pay attention to the policy dynamics of the National Medical Insurance Administration and learn about various supplementary medical insurance and charity assistance projects to reduce the financial burden of medication.